L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea · Delayed Price · Currency is KRW 76,900
-7,500 (-8.89%)
Jun 12, 2026, 3:30 PM KST
L&C BIO Co.,LTD Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, L&C BIO Co.,LTD stock has a consensus rating of "Buy" and an average price target of ₩95,000. The average 1-year stock price forecast is 23.54% higher than the current stock price, while the lowest is ₩80,000 (+4.03%) and the highest is ₩114,000 (+48.24%).
Price Target: ₩95,000 (+23.54%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for L&C BIO Co.,LTD stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 3 | 3 |
Financial Forecast
Revenue This Year
173.53B
from 85.48B
Increased by 103.02%
Revenue Next Year
284.62B
from 173.53B
Increased by 64.01%
EPS This Year
1.07K
from -5.81K
EPS Next Year
2.15K
from 1.07K
Increased by 100.08%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 179.0B | ||
| Avg | 173.5B | ||
| Low | 167.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 109.4% | ||
| Avg | 103.0% | ||
| Low | 95.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,198.58 | ||
| Avg | 1,072.25 | ||
| Low | 988.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |